Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population

about

Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population

Item

http://www.wikidata.org/entity/Q37310597

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inflammatory markers and clini ...... e assay in dialysis population

@en

Inflammatory markers and clini ...... assay in dialysis population.

@nl

type

Item

label

Inflammatory markers and clini ...... e assay in dialysis population

@en

Inflammatory markers and clini ...... assay in dialysis population.

@nl

prefLabel

Inflammatory markers and clini ...... e assay in dialysis population

@en

Inflammatory markers and clini ...... assay in dialysis population.

@nl

P1476

Inflammatory markers and clini ...... e assay in dialysis population

@en

P2093

Chih-Yuan Lee

http://www.w3.org/2001/XMLSchema#string

Feng-Jung Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis

Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.

Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.

High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test.

Transection of the oesophagus for bleeding oesophageal varices.

Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice

Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

Tuberculosis in chronic kidney disease.

Tuberculosis in patients with end-stage renal disease.

P2888

srep34577

P304

34577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP34577

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27703202

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis

P932

5050411

http://www.w3.org/2001/XMLSchema#string